Adipose Mesenchymal Stem Cell‐Derived Exosomes Versus Platelet‐Rich Plasma Treatment for Photoaged Facial Skin: An Investigator‐Blinded, Split‐Face, Non‐Inferiority Trial
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70208 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Blanca Estupiñan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Skin Laser & Surgery Specialists, a Division of Schweiger Dermatology Group, Hackensack, New Jersey, USA. Hauptthemen laut MEDLINE: Cosmetic Techniques, Exosomes, Mesenchymal Stem Cells, Platelet-Rich Plasma. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Exosomes, an emerging treatment of interest to aesthetic dermatology, have therapeutic applications in skin rejuvenation, alopecia, atopic dermatitis, acne scarring, and wound healing. Platelet‐rich plasma has been widely utilized for the same indications, among others. Currently, there are no trials comparing the two regenerative modalities in aesthetic dermatology.
Aims
To compare the efficacy and safety of adipose mesenchymal stem cell‐derived (ASC) exosomes versus platelet‐rich plasma for photoaged facial skin.
Methods
An investigator‐blinded, split‐face trial was conducted. Participants with mild to moderate photoaging underwent three radiofrequency microneedling treatments with PRP and topical exosomes each applied to one half of the face.
Results
Both exosomes and PRP equally improved wrinkling, dyschromia, erythema, texture, and overall skin appearance. Histological analysis confirmed increased collagen I and glycosaminoglycans, without significant differences between treatment arms.
Conclusion
ASC exosomes are a promising PRP‐alternative that may be attractive to needle‐averse patients and can hasten the office visit duration, as phlebotomy and centrifugation are not required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Skin Laser & Surgery Specialists, a Division of Schweiger Dermatology Group, Hackensack, New Jersey, USA.
- Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York, New York, USA.
ORCID-Profile: David J Goldberg
Zitieren
APA
Estupiñan, B., Ly, K., & Goldberg, D. J. (2025). Adipose Mesenchymal Stem Cell‐Derived Exosomes Versus Platelet‐Rich Plasma Treatment for Photoaged Facial Skin: An Investigator‐Blinded, Split‐Face, Non‐Inferiority Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70208
Vancouver
Estupiñan B, Ly K, Goldberg DJ. Adipose Mesenchymal Stem Cell‐Derived Exosomes Versus Platelet‐Rich Plasma Treatment for Photoaged Facial Skin: An Investigator‐Blinded, Split‐Face, Non‐Inferiority Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70208
BibTeX
@article{Estupian2025,
author = {Estupiñan, Blanca and Ly, Karen and Goldberg, David J},
title = {Adipose Mesenchymal Stem Cell‐Derived Exosomes Versus Platelet‐Rich Plasma Treatment for Photoaged Facial Skin: An Investigator‐Blinded, Split‐Face, Non‐Inferiority Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70208}
}
EUVIMED